FDA on Friday approved Lexicon’s heart failure drug Sotagliflozin Read More… (FDA had earlier rejected the drug for Type 1 Diabetese. Europe had approved Sotagliflozin as Zynquista for Type 1 Diabetese, however later EU withdrew Marketing Authorisation on the request of MA holder Guidehouse Germany GmbH)

1 minute read

Updated on May 31, 2023

</a> Marketing Authorisation on the request of MA holder Guidehouse Germany GmbH)

Discussion forum for Pharma Quality events, Regulatory Actions